The tweet was deleted by the author.
But we saved everything 🙂.
Accuray introduces enhanced flexibility and confidence in helical treatment delivery with its Radixact and Accuray Helix solutions at ESTRO26.
The company is focusing on advancing radiotherapy technologies, aiming to improve precision and patient outcomes. The announcement at ESTRO26 highlights Accuray's commitment to innovation in cancer treatment through state-of-the-art equipment.
Accuray has previously reported clinical outcomes with its systems. A company study found that helical TomoTherapy delivered less xerostomia than VMAT in patients with advanced nasopharyngeal carcinoma. The results were linked to improved sparing of the parotid glands during treatment.